Targeting the MAGED2-TRIM28-FLNC axis overcomes chemoresistance in TNBC via EMT suppression
Qifan Luo, Le Chen, Sai Zhao, Lei Wei, Yihao Tian, Jingwei Zhang · 2025
Read Targeting the MAGED2-TRIM28-FLNC axis overcomes chemoresistance in TNBC via EMT suppression by Qifan Luo, Le Chen, Sai Zhao, Lei Wei, Yihao Tian, Jingwei Zhang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12751829.txt.
Description
Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with a poor response to chemotherapy. Fewer than 40% of patients achieve a complete pathological response to neoadjuvant chemotherapy, demonstrating the chemoresistance characteristic of TNBC. Here, we analyze proteomic and transcriptomic datasets of TNBC patients treated with neoadjuvant chemotherapy and identify MAGED2 as a critical regulator of chemoresistance.
Catalog record
| CREATOR | Qifan Luo, Le Chen, Sai Zhao, Lei Wei, Yihao Tian, Jingwei Zhang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 68 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |